King Andrew James - Insider Non-Derivative Transactions at CHINOOK THERAPEUTICS, INC. (KDNY) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Aug 11, 2023, King Andrew James's relationship to CHINOOK THERAPEUTICS, INC. (KDNY) is Officer (Chief Scientific Officer), and currently has 0 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KDNY insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

King Andrew James - Insider Non-Derivative Transactions of KDNY Common Stock

King Andrew James - Insider Non-Derivative Transactions at KDNY

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Aug 12, 2023	Disposition -- (Common Stock)	19157	0	0
Aug 2, 2023	Sell -- (Common Stock)	1168	39.03	19157
Jul 30, 2023	M -- (Common Stock)	3333	0	20325
Apr 4, 2023	Sell -- (Common Stock)	5000	23.34	16992
Apr 4, 2023	M -- (Common Stock)	2500	0.35	21992
Feb 11, 2023	Sell -- (Common Stock)	2392	23.75	19492
Feb 11, 2023	M -- (Common Stock)	6803	0	21884
Feb 1, 2023	Sell -- (Common Stock)	3244	24.68	15081
Feb 1, 2023	M -- (Common Stock)	8333	0	18325
Jan 4, 2023	Sell -- (Common Stock)	10000	25.82	9992
Jan 4, 2023	M -- (Common Stock)	7500	0.35	19992